Cargando…
Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154410/ https://www.ncbi.nlm.nih.gov/pubmed/37130896 http://dx.doi.org/10.1038/s41392-023-01394-8 |
| _version_ | 1785036120670601216 |
|---|---|
| author | Xia, Leiming Tian, Wanlu Zhao, Yiming Jiang, Lingling Qian, Wei Jiang, Lei Ge, Ling Li, Jianjun Jin, Fengbo Yang, Mingzhen |
| author_facet | Xia, Leiming Tian, Wanlu Zhao, Yiming Jiang, Lingling Qian, Wei Jiang, Lei Ge, Ling Li, Jianjun Jin, Fengbo Yang, Mingzhen |
| author_sort | Xia, Leiming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10154410 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101544102023-05-04 Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy Xia, Leiming Tian, Wanlu Zhao, Yiming Jiang, Lingling Qian, Wei Jiang, Lei Ge, Ling Li, Jianjun Jin, Fengbo Yang, Mingzhen Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-05-03 /pmc/articles/PMC10154410/ /pubmed/37130896 http://dx.doi.org/10.1038/s41392-023-01394-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Xia, Leiming Tian, Wanlu Zhao, Yiming Jiang, Lingling Qian, Wei Jiang, Lei Ge, Ling Li, Jianjun Jin, Fengbo Yang, Mingzhen Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy |
| title | Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy |
| title_full | Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy |
| title_fullStr | Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy |
| title_full_unstemmed | Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy |
| title_short | Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy |
| title_sort | venetoclax and azacitidine in chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154410/ https://www.ncbi.nlm.nih.gov/pubmed/37130896 http://dx.doi.org/10.1038/s41392-023-01394-8 |
| work_keys_str_mv | AT xialeiming venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT tianwanlu venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT zhaoyiming venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT jianglingling venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT qianwei venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT jianglei venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT geling venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT lijianjun venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT jinfengbo venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy AT yangmingzhen venetoclaxandazacitidineinchinesepatientswithuntreatedacutemyeloidleukemiaineligibleforintensivechemotherapy |